Young Doug Sohn

Young Doug Sohn is a highly experienced scientist and biotech executive with a career spanning over three decades. He currently holds the position of Director at Karis Bio USA, where he oversees key initiatives in biotechnology. Concurrently, he serves as a Staff Scientist at Emory University School of Medicine, contributing to significant advancements in stem cell biology, biomaterials, and cardiovascular disease. He has been with Emory since 2008, starting as a Postdoctoral Researcher and later becoming a Research Associate in 2016. His work has focused on adult stem cell biology and cell reprogramming for cardiovascular disease, areas where he has developed deep expertise.

Prior to his current roles, Sohn was the Executive Director of NC-bit Inc., where he led new drug development efforts and managed executive functions for nearly six years. He also served as Vice President and Director of Research at Biobud Inc., where he guided research initiatives and managed operations at the company’s research center in Seoul. Earlier in his career, he spent seven years as a Research Scientist at Mogam Biotechnology Research Institute, where he developed recombinant protein expression systems in the Molecular Biology Lab.

Sohn’s extensive background in both scientific research and executive management positions him as a leader in the fields of stem cell biology, biotechnology, and cardiovascular disease research. His contributions have had a significant impact on the development of new therapeutic strategies and the advancement of biotech research.